Back

Estimating the allele frequency threshold of the pathogenic mtDNA variant m.3243A>G tolerated by human myofibres

Ahmed, S. T.; Taylor, R. W.; Turnbull, D. M.; Lawless, C.; Pickett, S. J.

2022-04-05 pathology
10.1101/2022.04.04.22272484 medRxiv
Show abstract

BackgroundPathogenic mitochondrial (mt)DNA variants cause neuromuscular disease with highly variable severity and phenotypic presentation, the reason for which is poorly understood. Cells are thought to tolerate the presence of pathogenic mtDNA variants up to a threshold proportion with little or no functional consequence, developing significant respiratory complex defects above this threshold. We developed a robust method to identify deficient muscle fibres, applied it to biopsies from 17 patients carrying the common m.3243A>G variant and examined the relationship between respiratory deficiency and m.3243A>G level in hundreds of single skeletal muscle fibres. We hypothesised that single-cell between-patient differences may explain the vast clinical heterogeneity of mtDNA disease. ResultsImmunohistochemical measurements of respiratory complexes I and IV and unsupervised machine learning identified muscle fibres with respiratory deficiency; the pattern of deficiency and proportion of deficient fibres (range 0-64%) varies between patients. Tissue homogenate m.3243A>G level is a poor surrogate for the broad and complex distributions of m.3243A>G level in single cells from individual patients. Estimated thresholds do not differ between patients, but sections with narrow m.3243A>G distributions have a lower proportion of deficient fibres. ConclusionsInter-individual differences in respiratory complex deficiency in muscle fibres from patients with m.3243A>G are more complex than previously thought and may be driven by differential segregation and expansion of mtDNA molecules. Our quantitative observations could constrain the range of feasible mechanisms responsible for phenotypic diversity in mitochondrial disease.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Skeletal Muscle
14 papers in training set
Top 0.1%
35.9%
2
PLOS ONE
4510 papers in training set
Top 32%
4.5%
3
Human Molecular Genetics
130 papers in training set
Top 0.9%
2.9%
4
The Lancet
16 papers in training set
Top 0.1%
2.7%
5
Scientific Reports
3102 papers in training set
Top 43%
2.7%
6
BMC Medicine
163 papers in training set
Top 2%
2.2%
50% of probability mass above
7
Science Translational Medicine
111 papers in training set
Top 2%
2.0%
8
JCI Insight
241 papers in training set
Top 3%
1.9%
9
Annals of Clinical and Translational Neurology
29 papers in training set
Top 0.5%
1.8%
10
The American Journal of Pathology
31 papers in training set
Top 0.2%
1.8%
11
Genetics in Medicine
69 papers in training set
Top 0.6%
1.8%
12
Muscle & Nerve
10 papers in training set
Top 0.2%
1.6%
13
Nature Communications
4913 papers in training set
Top 55%
1.4%
14
Neuropathology and Applied Neurobiology
14 papers in training set
Top 0.3%
1.4%
15
Journal of Clinical Pathology
12 papers in training set
Top 0.2%
1.4%
16
eBioMedicine
130 papers in training set
Top 2%
1.3%
17
Disease Models & Mechanisms
119 papers in training set
Top 2%
1.3%
18
Emerging Infectious Diseases
103 papers in training set
Top 2%
1.2%
19
Frontiers in Neurology
91 papers in training set
Top 4%
0.9%
20
American Journal of Respiratory and Critical Care Medicine
39 papers in training set
Top 0.7%
0.9%
21
Communications Biology
886 papers in training set
Top 20%
0.8%
22
NAR Genomics and Bioinformatics
214 papers in training set
Top 3%
0.8%
23
Modern Pathology
21 papers in training set
Top 0.4%
0.8%
24
Clinical Infectious Diseases
231 papers in training set
Top 4%
0.8%
25
Neurology
44 papers in training set
Top 1%
0.8%
26
Life Science Alliance
263 papers in training set
Top 1%
0.8%
27
Mitochondrion
11 papers in training set
Top 0.1%
0.8%
28
Journal of Clinical Investigation
164 papers in training set
Top 6%
0.8%
29
Aging Cell
144 papers in training set
Top 3%
0.8%
30
BMC Methods
11 papers in training set
Top 0.2%
0.8%